BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update

Brainstorm Cell Therapeutics (BCLI) Tops Q3 EPS by 12c

October 15, 2020 7:03 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.14), $0.12 better than the analyst estimate of ($0.26).

Financial Results for the Three Months Ended September 30, 2020

Cash and cash equivalents, and short-term bank deposits amounted to approximately $28.8 million at September 30, 2020 compared to $16.2 million at June 30, 2020.Research and development expenses, net for the three months ended September 30, 2020 and 2019 were $1.87 million and $4.01 million, respectively.Excluding participation from IIA and CIRM under the grants and proceeds received under the hospital exemption regulatory pathway, research and development expenses decreased by $1.68 million from $5.66 million in the... More